About Us

Home > About Us

Your Partner for Success

As the investment division of Viva Biotech Holdings (1873.HK), Viva BioInnovator (VBI) is dedicated to the identification and success of early-stage biotech start-ups through our incubation, equity-for-service, and investment platforms. We are committed to operating a collaborative platform for innovative biotech companies and anyone developing an idea with transformative potential.  By leveraging our rich industry experience and technical advantages, VBI can provide R&D, working sites, logistic support, industrial docking, investment, and more to accelerate the transformation and commercialization of new drug discovery around the world. Visit vivabioinnovator.com for more information.

Our Advantages

We Provide the 5 Key Ingredients to Start and Grow a Biotech Company

Strategy

+       Strong Team

We insist the founders have strong integrity and a track record of company building and new drug R&D.

+       Groundbreaking Innovation

The “idea” needs to be innovative.

+       Patient Impact

There must be a true unmet medical need.

+       Market Demand

There must be significant market potential 5-10 years in the future. 

+       Focus
Primarily innovative/novel therapeutics

+       Funding
Seed round to A-round stages, average investment amount between $0.5 million - $5 million

+       Investment Type
Cash, EFS, or a combination of EFS & Cash